Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial.

Saved in:
Bibliographic Details
Title: Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial.
Authors: Garg SK (AUTHOR), Mathieu C (AUTHOR), Rais N (AUTHOR), Gao H (AUTHOR), Tobian JA (AUTHOR), Gates JR (AUTHOR), Ferguson JA (AUTHOR), Webb DM (AUTHOR), Berclaz PY (AUTHOR)
Source: Diabetes Technology & Therapeutics. 2009 Sep Suppl 2, Vol. 11, pS5-16. 1p.
Database: Academic Search Ultimate
Description
ISSN:15209156
DOI:10.1089/dia.2009.0040